chartexchange

CALC
CalciMedica, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:30 PM EST
1.20USD-1.639%(-0.02)34,245
After-hoursNov 18, 2026 4:00:30 PM EST
1.17USD-2.500%(-0.03)
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Jolla, CA, USA
Previous Close
$1.22
Beta
0.88
52-Week High
$36.00 2026-01-02
52-Week Low
$1.00 2026-10-19
SMA 50
$1.48
SMA 200
$2.94
Avg. Vol 10D
43,945
Avg. Vol 30D
77,376
Avg. Vol 90D
74,801
Relative Vol
0.44
3.46M
96.2800%
1,372
Aug 31, 2026 · 1-for-5 (reverse)
CALC Profile

calcimedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune disorders, organ transplant rejection, and other immune diseases.

CALC Performance
PeriodPriceDateChangeBeta
1W1.222026-11-12-3.28%-0.887
1M1.022026-10-19+15.69%1.830
3M3.072026-08-19-61.51%1.343
6M3.092026-05-19-61.77%0.683
1Y15.782025-11-19-92.52%0.880
2Y16.752024-11-19-92.95%—
5Y31.652023-03-21-96.27%0.108
CALC Stock Summary

CalciMedica, Inc. Common Stock (NASDAQ:CALC) stock price today is $1.18, and today's volume is 34,245. CALC is down 3.279% today. The 30 day average volume is 77,376. CALC market cap is $8.14M with 6.90M shares outstanding.